More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

inhibitors — these help a person’s pancreas produce more insulin and less glucagon, to reduce their blood glucose levels glucagon-like peptide-1 (GLP-1) receptor agonists — these stimulate insulin ...

Conventional markers used for diagnosing and managing diabetes have recently come to question. This blog addresses some of ...

Insulin, a hormone produced by the pancreas, plays a major role in blood ... When this occurs, you need someone to give you glucagon. Glucagon is a hormone produced in the pancreas that stimulates ...

This triggers the pancreas to make and release more glucagon ... Read more about how insulin and glucagon regulate blood sugar. Most research has involved animals rather than humans.

As a result, semaglutide and its fellow glucagon-like peptide-1 drugs ... The substance stimulates the pancreas to release insulin, lowering glucose in the blood to keep blood sugar in balance.

GLP-1 is a hormone made naturally in the gut. It plays a big role in managing blood sugar and appetite while releasing ...